Lantern Pharma (NASDAQ:LTRN – Get Free Report) is expected to be announcing its earnings results before the market opens on ...
Hosted on MSN1mon
Lantern Pharma Inc. (LTRN) Enhances RADR® AI Platform to Accelerate Development of Antibody-Drug Conjugates (ADCs) for Targeted Cancer TherapiesLantern Pharma Inc. (NASDAQ ... AI platform aimed at accelerating and optimizing the development of antibody-drug conjugates (ADCs). ADC is a process of creating Antibody-Drug Conjugates, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results